These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Microencapsulation of new probiotic formulations for gastrointestinal delivery: in vitro study to assess viability and biological properties. D'Orazio G; Di Gennaro P; Boccarusso M; Presti I; Bizzaro G; Giardina S; Michelotti A; Labra M; La Ferla B Appl Microbiol Biotechnol; 2015 Nov; 99(22):9779-89. PubMed ID: 26239070 [TBL] [Abstract][Full Text] [Related]
24. Anti-inflammatory effect of multistrain probiotic formulation (L. rhamnosus, B. lactis, and B. longum). Sichetti M; De Marco S; Pagiotti R; Traina G; Pietrella D Nutrition; 2018 Sep; 53():95-102. PubMed ID: 29674267 [TBL] [Abstract][Full Text] [Related]
25. Health benefits of Szajewska H; Hojsak I Postgrad Med; 2020 Jun; 132(5):441-451. PubMed ID: 32059116 [TBL] [Abstract][Full Text] [Related]
26. Specific probiotic dietary supplementation leads to different effects during remission and relapse in murine chronic colitis. Zheng B; van Bergenhenegouwen J; van de Kant HJ; Folkerts G; Garssen J; Vos AP; Morgan ME; Kraneveld AD Benef Microbes; 2016; 7(2):205-13. PubMed ID: 26645352 [TBL] [Abstract][Full Text] [Related]
27. Clinical studies on alleviating the symptoms of irritable bowel syndrome. Kajander K; Korpela R Asia Pac J Clin Nutr; 2006; 15(4):576-80. PubMed ID: 17077079 [TBL] [Abstract][Full Text] [Related]
28. [The results of the use of a combined probiotic ( Vorobieva OA; Shih EV; Drozdov VN; Shikh NV Vopr Pitan; 2023; 92(3):79-86. PubMed ID: 37432710 [TBL] [Abstract][Full Text] [Related]
29. Effect of a Preparation of Four Probiotics on Symptoms of Patients with Irritable Bowel Syndrome: Association with Intestinal Bacterial Overgrowth. Leventogiannis K; Gkolfakis P; Spithakis G; Tsatali A; Pistiki A; Sioulas A; Giamarellos-Bourboulis EJ; Triantafyllou K Probiotics Antimicrob Proteins; 2019 Jun; 11(2):627-634. PubMed ID: 29508268 [TBL] [Abstract][Full Text] [Related]
30. Evaluating the Efficacy of Probiotics in IBS Treatment Using a Systematic Review of Clinical Trials and Multi-Criteria Decision Analysis. Ceccherini C; Daniotti S; Bearzi C; Re I Nutrients; 2022 Jun; 14(13):. PubMed ID: 35807868 [TBL] [Abstract][Full Text] [Related]
31. Combination of Li SC; Hsu WF; Chang JS; Shih CK Nutrients; 2019 Apr; 11(5):. PubMed ID: 31035617 [TBL] [Abstract][Full Text] [Related]
32. Probiotic properties and the ameliorative effect on DSS-induced colitis of human milk-derived Lactobacillus gasseri SHMB 0001. Wang X; Dong F; Liu G; Ye L; Xiao F; Li X; Zhang T; Wang Y J Food Sci; 2024 May; 89(5):3078-3093. PubMed ID: 38605580 [TBL] [Abstract][Full Text] [Related]
33. Mucosal permeability and immune activation as potential therapeutic targets of probiotics in irritable bowel syndrome. Barbara G; Zecchi L; Barbaro R; Cremon C; Bellacosa L; Marcellini M; De Giorgio R; Corinaldesi R; Stanghellini V J Clin Gastroenterol; 2012 Oct; 46 Suppl():S52-5. PubMed ID: 22955358 [TBL] [Abstract][Full Text] [Related]
34. Effects of multispecies probiotic combination on helicobacter pylori infection in vitro. Myllyluoma E; Ahonen AM; Korpela R; Vapaatalo H; Kankuri E Clin Vaccine Immunol; 2008 Sep; 15(9):1472-82. PubMed ID: 18579692 [TBL] [Abstract][Full Text] [Related]
35. Probiotic Consortia and Their Metabolites Ameliorate the Symptoms of Inflammatory Bowel Diseases in a Colitis Mouse Model. Xu L; Liu B; Huang L; Li Z; Cheng Y; Tian Y; Pan G; Li H; Xu Y; Wu W; Cui Z; Xie L Microbiol Spectr; 2022 Aug; 10(4):e0065722. PubMed ID: 35730951 [TBL] [Abstract][Full Text] [Related]
36. Adjunctive treatment with probiotics partially alleviates symptoms and reduces inflammation in patients with irritable bowel syndrome. Xu H; Ma C; Zhao F; Chen P; Liu Y; Sun Z; Cui L; Kwok LY; Zhang H Eur J Nutr; 2021 Aug; 60(5):2553-2565. PubMed ID: 33225399 [TBL] [Abstract][Full Text] [Related]
37. Antioxidant and Anti-Inflammatory Properties of Probiotic Candidate Strains Isolated during Fermentation of Agave ( Hernández-Delgado NC; Torres-Maravilla E; Mayorga-Reyes L; Martín R; Langella P; Pérez-Pastén-Borja R; Sánchez-Pardo ME; Bermúdez-Humarán LG Microorganisms; 2021 May; 9(5):. PubMed ID: 34069080 [TBL] [Abstract][Full Text] [Related]
38. The Effectiveness and Safety of Multi-Strain Probiotic Preparation in Patients with Diarrhea-Predominant Irritable Bowel Syndrome: A Randomized Controlled Study. Skrzydło-Radomańska B; Prozorow-Król B; Cichoż-Lach H; Majsiak E; Bierła JB; Kanarek E; Sowińska A; Cukrowska B Nutrients; 2021 Feb; 13(3):. PubMed ID: 33652763 [TBL] [Abstract][Full Text] [Related]